|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Transarterial chemoembolization and bland embolization for hepatocellular carcinoma显示文摘Transarterial chemoembolization(TACE)is the first line treatment for patients with intermediate stage hepatocellular carcinoma but is also increasingly being used for patients on the transplant waiting list to prevent further tumor growth.Despite its widespread use,TACE remains an unstandardized procedure,with variation in type and size of embolizing particles,type and dose of chemotherapy and interval between therapies.Existing evidence from randomized controlled trials suggest that bland transarterial embolization(TAE)has the same efficacy with TACE.In the current article,we review the use of TACE and TAE for hepatocellular carcinoma and we focus on the evidence for their use. | Emmanuel A Tsochatzis Evangelia Fatourou James O'Beirne Tim Meyer Andrew K Burroughs | 2014 | World Journal of Gastroenterology2014，20，12： | 18 |
| 2 | E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma显示文摘 | Marina Palaiologou John Koskinas Menelaos Karanikolas Evangelia Fatourou Dina Tiniakos | 2012 | Virchows Archiv2012，，5： | 2 |
| 3 | Liposmes encapsulating prednisolone and prednisolone-cyclodextrin complexs:comparison of membrane integrity and drug release显示文摘 | Fatourous DG Hatzidimitiou K Antimisiaris SG | 2001 | Eur J Pharm Sci2001，13，4： | 1 |
| 4 | The role of established and emerging risk factors in peripheral vascular graft occlusion显示文摘 | Fatourou EM Paraskevas KI Seifalian AM | 2007 | Expert Opin Pharmacother2007，8，7： | 1 |
| 5 | Targeting VEGF,EGFR,and other interacting pathways for gastric cancer-promises and reality显示文摘 | Liakakos T Fatourou E Ziogas D | 2008 | Ann Surg Oncol2008，15，10： | 1 |
| 6 | Transarterial embolization as neo‐adjuvant therapy pretransplantation in patients with hepatocellular carcinoma显示文摘 | Emmanuel Tsochatzis Matteo Garcovich Laura Marelli Vassilis Papastergiou Evangelia Fatourou Manuel L. Rodriguez‐Peralvarez Giacomo Germani Neil Davies Dominic Yu Tu Vinh Luong Amar P. Dhillon Douglas Thorburn David Patch James O’Beirne Tim Meyer Andrew K. | 2013 | Liver Int2013，，6： | 1 |
| 7 | Ziogas targeting VEGF,EGFR,and other interacting pathways for gastric cancer - promisesand reality显示文摘 | Liakakos T Fatourou E Ziogas D | 2008 | Ann Surg Oncol2008，15，10： | 1 |
| 8 | Contribution of vasogenic and cellular edema to traumatic brain显示文摘 | Barzo P Marmarou A Fatoures P | 1997 | Neu- rosurg1997，86，4： | 1 |
| 9 | Magnetic reso- nance imaging monitored acute blood brain barrier changes in experimental traumatic brain injury显示文摘 | Barzo P Marmamu A Fatoures P | 1996 | Neuro- surg1996，85，7： | 1 |
| 10 | Targeting VEGF,EGFR,and other interacting pathways for gastric cancer-promises and reality显示文摘 | Liakakos T Fatourou E Ziogas D | 2008 | Ann Surg Oneo12008，15，10： | 1 |
| 11 | Targeting VEGF, EGFR,and other interacting pathways for gastric cancer-promises and reality显示文摘 | Liakakos T Fatourou E Ziogas D | 2008 | Ann Surg Oncol2008，15，10： | 1 |
| 12 | Targeting VEGF, EGFR, and other interacting pathways for gastric cancer promises and reality 显示文摘 | Liakakos T Fatourou E Ziogas D | 2008 | Ann Surg Oncol2008，15，10： | 1 |
| 13 | The role of established and emerging risk factors in peripheral vascular graft occlusion显示文摘 | Fatourou EM Paraskevas KI Seifalian AM | 2007 | Expert Opin Pharmaeother2007，8，7： | 1 |
| 14 | Liver disease in adult transfusion‐dependent beta‐thalassaemic patients: investigating the role of iron overload and chronic HCV infection显示文摘 | Dimitrios Kountouras Nikolaos J. Tsagarakis Evangelia Fatourou Efthimios Dalagiorgos Nikolaos Chrysanthos Helen Berdoussi Niki Vgontza Markissia Karagiorga Athanasios Lagiandreou Konstantinos Kaligeros Ersi Voskaridou Paraskevi Roussou Evanthia Diamanti‐K | 2013 | Liver Int2013，，3： | 1 |
| 15 | E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma显示文摘 | Marina Palaiologou John Koskinas Menelaos Karanikolas Evangelia Fatourou Dina G. Tiniakos | 2012 | Virchows Archiv2012，，5： | 1 |
| 16 | Targeting VEGF,EGFR,and other interacting pathways for gastric cancer-promises and reality显示文摘 | Liakakos T Fatourou E Ziogas D | 2008 | Ann Surg Oncol2008，15，10： | 1 |
| 17 | Adaptive immunity in hepatocellular carcinoma : prognostic and therapeutic implications 显示文摘 | Fatourou EM Koskinas JS | 2009 | Expert Rev Anticancer Ther2009，9，10： | 1 |
| 18 | Transarterial embolization as neo‐adjuvant therapy pretransplantation in patients with hepatocellular carcinoma显示文摘 | Emmanuel Tsochatzis Matteo Garcovich Laura Marelli Vassilis Papastergiou Evangelia Fatourou Manuel L. Rodriguez‐Peralvarez Giacomo Germani Neil Davies Dominic Yu Tu Vinh Luong Amar P. Dhillon Douglas Thorburn David Patch James O’Beirne Tim Meyer Andrew K. | 2013 | Liver Int2013，，6： | 1 |
| 19 | Adaptive immunity in hepatocellularcarcinoma: prognostic and therapeutic implications显示文摘 | Fatourou EM Koskinas JS | 2009 | Expert RevAnticancer Ther2009，9，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员